GNMK Quote, Trading Chart, GenMark Diagnostics Inc.
home / stock / gnmk / gnmk quote
$19.34 Last:
4.15% Change Percent:
$18.56 Open:
$19.34 Previous Close:
$19.44 High:
$17.69 Low:
930,364 Volume:
03/05/2021 04:55:33 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-05 | 18.56 | 19.34 | 19.44 | 17.69 | 930,364 |
| 2021-03-04 | 18.86 | 18.57 | 19.66 | 18.121 | 1,312,354 |
| 2021-03-03 | 18.88 | 19.05 | 19.49 | 18.5 | 860,789 |
| 2021-03-02 | 19.09 | 18.94 | 20.126 | 18.87 | 791,789 |
| 2021-03-01 | 19.19 | 19.05 | 19.62 | 18.41 | 927,984 |
| 2021-02-26 | 17 | 19.55 | 19.88 | 16.904 | 1,966,682 |
| 2021-02-25 | 19.16 | 18.8 | 19.48 | 18.62 | 1,100,322 |
| 2021-02-24 | 19.12 | 19.29 | 19.69 | 19.08 | 573,893 |
| 2021-02-23 | 19.35 | 19.265 | 19.75 | 18.32 | 1,080,949 |
| 2021-02-22 | 20.36 | 19.82 | 20.77 | 19.51 | 881,733 |
| 2021-02-19 | 21.8 | 20.68 | 21.8 | 20.28 | 1,215,293 |
| 2021-02-18 | 21.63 | 21.66 | 22.28 | 21.32 | 498,782 |
| 2021-02-17 | 21.55 | 21.84 | 21.94 | 21.1148 | 778,626 |
| 2021-02-16 | 23.43 | 21.77 | 23.59 | 20.95 | 1,800,546 |
| 2021-02-15 | 21.55 | 22.74 | 22.8 | 21.18 | 1,694,087 |
| 2021-02-12 | 21.55 | 22.74 | 22.8 | 21.18 | 1,685,009 |
| 2021-02-11 | 19.27 | 22.45 | 23.49 | 19.1 | 7,778,643 |
| 2021-02-10 | 17 | 16.86 | 17.78 | 16.54 | 875,510 |
| 2021-02-09 | 14.73 | 16.86 | 17.72 | 14.67 | 2,756,928 |
| 2021-02-08 | 15 | 14.86 | 15.0906 | 14.37 | 1,007,956 |
GenMark Diagnostics Inc. Company Name:
GNMK Stock Symbol:
NASDAQ Market:
GenMark Diagnostics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
CARLSBAD, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fiscal year and quarter ended December 31, 2020. Full Year 20...
-
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that its ePlex Respiratory Pathogen Panel 2 (RP2) is predicted to detect known SARS-CoV-2 variants c...
-
CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in th...